Bhavika Chouhan, Zainab Mastim, Anshi Jaiswal and Syeda Inaya.
High altitude environments present a unique physiology challenge to the human body. As altitude increases atmospheric pressure decreases, leading to reduced partial pressure of oxygen,and consequently lower atrial saturation(SpO2). The chronic hypoxia exposure initiates a cascade of compensatory mechanisms affecting the cardiovascular, renal, respiratory and hematological systems.
Over time, these changes may transition from adaptive to maladaptive, contributing to the development of hypertension both systemic and pulmonary. Interestingly, population residing permanently at high altitude exhibit a remarkable physiological and genetic adaptations, whereas migrants and non-autoimmune individuals often experience exaggerated cardiovascular responses.
This article explores the complex relationship between altitude and hypertension, about how altitude affects blood pressure, focusing on the differences between populations, and patterns seen in Kyrgyzstan. It also includes real-life blood pressure observations among Indian, Pakistani, and Egyptian immigrants, along with Kyrgyz people living in Kyrgyzstan.
The aim of this study is to synthesis current evidence on hypertension at high altitude by Analyzing pathophysiological mechanism, Evaluating environmental and lifestyle determinants, Comparing adapted vs non-adapted populations, Assessing effects of altitude transition in: Healthy individuals, Hypertensive patients, Migrants and Special emphasis is placed on population.
This study utilizes an integrated evidence synthesis of peer-reviewed literature from PubMed, Scopus, and the Cochrane Library (2010–2026). The search focused on the pathophysiology of High-Altitude Systemic Hypertension (HASH) and interprofessional management models.
Inclusion and Stratification
Pathophysiology: Mechanisms of SNS overactivation, nitric oxide (NO) depletion, and HIF-1α/2α signaling.
Comparative Genomics: Phenotypic divergence between adapted (Tibetan/Ethiopian) and maladapted (Andean/Kyrgyz) cohorts.
Statistical Comparative Presentation: MPAP and HCT divergence between adapted (Tibetan/Ethiopian) and maladapted (Andean/Kyrgyz) cohorts.
Hemorheology: Impact of erythrocytosis and hyperviscosity on systemic vascular resistance.
Comparative and Clinical Analysis
Data were analyzed via a cross-sectional comparison of Mean Arterial Pressure (MAP) and Mean Pulmonary Artery Pressure (mPAP) across global highlands. The synthesis integrated clinical guidelines from the International Society for Mountain Medicine and regional data (e.g., Kyrgyzstan STEPS surveys) to evaluate interprofessional healthcare models, specifically focusing on medication titration and dietary reformation in remote mountainous environments.
1. Pathophysiological Mechanisms and Clinical Implications
Sympathetic Nervous System Overactivation
At high altitudes, chronic hypoxia leads to SNS activation via the carotid body chemoreceptors, which triggers several cardiovascular changes:
• Increased heart rate and cardiac output
• Vasoconstriction of both systemic and pulmonary vasculature
• Increased systemic vascular resistance (SVR)
These changes initially serve to improve oxygen delivery but lead to sustained hypertension when the SNS remains chronically overactive. This is further compounded by the elevated blood viscosity seen in populations with excessive erythropoiesis.
Endothelial cells play a pivotal role in regulating vascular tone. At high altitudes, hypoxia reduces the bioavailability of nitric oxide (NO), a critical vasodilator, while increasing the production of endothelin-1 and thromboxane A₂, both of which contribute to vasoconstriction.
• Increased vascular resistance
• Vascular remodeling, characterized by medial hypertrophy and collagen deposition, leading to arterial stiffness and reduced compliance.
These vascular changes create a positive feedback loop, where increased SVR and decreased arterial compliance exacerbate hypertension.
High-altitude exposure increases erythropoietin (EPO) secretion, resulting in polycythemia (elevated RBC count). While this helps increase the oxygen-carrying capacity of blood, it also increases blood viscosity, contributing to:
• Increased vascular resistance
• Decreased blood flow velocity
• Thrombotic risks due to sluggish flow
The increased viscosity creates a hyper dynamic circulatory state that places extra strain on the heart, further contributing to hypertension.
2. Environmental Stress: Hypoxia and Cardiovascular Adaptations
The atmospheric pressure decreases as altitude increases, leading to lower levels of available oxygen (PaO₂). In response, the body initiates a series of compensatory mechanisms aimed at improving oxygen delivery to tissues. However, these mechanisms can also lead to maladaptive changes in the cardiovascular system, resulting in hypertension.
1. Erythropoiesis: To increase oxygen-carrying capacity, the kidneys secrete erythropoietin (EPO), stimulating the production of red blood cells (RBCs). This leads to polycythemia, which, while beneficial for oxygen delivery, increases blood viscosity.
2. Sympathetic Nervous System Activation: Hypoxia triggers carotid body chemoreceptors, leading to SNS activation and an increase in norepinephrine release. This results in vasoconstriction, increased heart rate, and higher cardiac output to improve tissue perfusion.
3. Pulmonary Vasoconstriction: Hypoxic pulmonary vasoconstriction helps direct blood flow to better-ventilated areas of the lungs, but this can also lead to pulmonary hypertension and increased right ventricular afterload.
These adaptive responses are essential for survival at high altitudes, but when sustained, they contribute to increased blood pressure and vascular remodeling, elevating the risk of cardiovascular complications.
HIF-1α and HIF-2α are key transcription factors that regulate the body’s response to low oxygen levels. Their activation leads to several crucial adaptive responses, including:
• Erythropoiesis: Increased production of EPO stimulates RBC formation.
• Angiogenesis: The upregulation of vascular endothelial growth factor (VEGF) promotes the growth of new blood vessels to enhance tissue oxygenation.
• Metabolic Shifts: Increased glycolytic enzyme production enhances anaerobic energy production, crucial in hypoxic conditions.
These molecular mechanisms, while vital for oxygen delivery and survival in hypoxic environments, also contribute to vascular stiffness, increased afterload, and hypertension over time.
3. Comparative Analysis of High-Altitude Populations
Tibetan populations living at high altitudes have evolved unique adaptations that limit the cardiovascular risks of chronic hypoxia. Key genetic differences include EPAS1 gene mutations, which optimize the HIF-2α pathway, enabling efficient oxygen use without excessive erythropoiesis. Unlike Andean populations, Tibetans have lower hemoglobin levels, which reduce the risks of hyper viscosity and pulmonary hypertension.
Clinical Implication: Tibetans exhibit lower rates of hypertension and related cardiovascular diseases compared to other high-altitude populations, indicating the role of genetic adaptation in reducing cardiovascular risk.
Andean populations, in contrast, exhibit marked polycythemia in response to hypoxia. While this adaptation increases oxygen-carrying capacity, it also leads to increased blood viscosity, higher systemic vascular resistance, and greater susceptibility to systemic hypertension. Excessive erythropoiesis and vascular remodeling contribute to the high incidence of hypertension and chronic mountain sickness (CMS) in these populations. Andean highlanders often experience pulmonary hypertension, right heart failure, and left ventricular hypertrophy due to chronic exposure to high-altitude conditions and the strain placed on the cardiovascular system.
Clinical Implication: The maladaptive features of Andean adaptation underscore the importance of tailored cardiovascular care for populations living at extreme altitudes. Specifically, the high incidence of polycythemia-induced hypertension necessitates close monitoring and early intervention to prevent cardiovascular disease and organ damage.
Section
Tibetan High Altitude Genetic Mutation For Adaptation
Andean High Altitude Adaptation: Maladaptive Features
Key points
Evolved unique adaptations limiting cardiovascular risks of chronic hypoxia - Key genetic differences include EPAS1 gene mutations, optimizing the HIF-2α pathway - Enables efficient oxygen use without excessive erythropoiesis - Lower hemoglobin levels reduce risks of hyper viscosity and pulmonary hypertension
Exhibit marked polycythemia in response to hypoxia - Increases oxygen-carrying capacity but also leads to increased blood viscosity, higher systemic vascular resistance, and greater susceptibility to systemic hypertension - Excessive erythropoiesis and vascular remodeling contribute to high incidence of hypertension and Chronic Mountain Sickness (CMS) - Often experience pulmonary hypertension, right heart failure, and left ventricular hypertrophy
Clinical Implication
Tibetans exhibit lower rates of hypertension and related cardiovascular diseases compared to other high-altitude populations, indicating the role of genetic adaptation in reducing cardiovascular risk
Underscores the importance of tailored cardiovascular care; high incidence of polycythemia-induced hypertension necessitates close monitoring and early intervention to prevent cardiovascular disease and organ damage
Ethiopian highlanders represent a distinct adaptive model. Unlike Tibetans and Andeans, Ethiopians living at high altitudes exhibit minimal polycythemia and efficient oxygen utilization. Their bodies adapt to hypoxia through increased tissue oxygen extraction rather than relying heavily on increased red blood cell production. This results in greater vascular compliance and lower blood viscosity, offering protection against hypertension and related cardiovascular risks.
Clinical Implication: Ethiopian populations demonstrate a lesser burden of hypertension compared to Andean populations, highlighting the diversity of high-altitude adaptations and the role of genetic factors in cardiovascular resilience
In Kyrgyz populations, chronic hypoxia leads to the remodeling of small pulmonary arteries. This doesn't just stay in the lungs, it contributes to right ventricular hypertrophy and systemic strain.
To compensate for low oxygen, the body produces more red blood cells. In many Kyrgyz highlanders, this leads to higher viscosity, increasing peripheral resistance and increasing blood pressure.
The traditional Kyrgyz dietary consumption which includes high sodium and animal fats via meat and dairy at high altitude creates a major risk on the vascular system.
Clinical Implications: Unlike the genetic cardiovascular resilience observed in other highlanders, Kyrgyz populations frequently exhibit high-Altitude Maladaptation, where chronic hypoxia triggers severe erythrocytosis and pulmonary vascular remodeling, necessitating aggressive interprofessional monitoring of cardiac hypertrophy and Dietary reformation is also necessary.
Section
Ethiopian Highlanders: A Unique Adaptive Response
Kyrgyz Highlanders: The Triple Threat
Key Points
Represent a distinct adaptive model unlike Tibetans and Andeans - Exhibit minimal polycythemia and efficient oxygen utilization - Bodies adapt via increased tissue oxygen extraction rather than increased red blood cell production - Results in greater vascular compliance and lower blood viscosity, offering protection against hypertension
Chronic hypoxia leads to remodeling of small pulmonary arteries, contributing to right ventricular hypertrophy and systemic strain - Body produces more red blood cells to compensate for low oxygen, increasing peripheral resistance and raising blood pressure - Traditional diet is high in sodium and animal fats (meat and dairy), creating a major additional risk on the vascular system
Clinical Implication
Ethiopian populations demonstrate a lesser burden of hypertension compared to Andean populations, highlighting the diversity of high-altitude adaptations and the role of genetic factors in cardiovascular resilience
Unlike genetic cardiovascular resilience in other highlanders, Kyrgyz populations frequently exhibit high-altitude maladaptation; chronic hypoxia triggers severe erythrocytosis and pulmonary vascular remodeling, necessitating aggressive interprofessional monitoring of cardiac hypertrophy and dietary reformation
4. Statistical Comparative Analysis of High-Altitude Populations
This is where the most dangerous variation occurs. Pulmonary pressure indicates how hard the right side of the heart is working.
Hemorhaelogical synthesis reveals a stark divergence in blood viscosity across high-altitude cohorts, characterized by an exponential increase in maladaptive phenotypes:Unlike genetic cardiovascular resilience in other highlanders, Kyrgyz populations frequently exhibit high-altitude maladaptation; chronic hypoxia triggers severe erythrocytosis and pulmonary vascular remodeling, necessitating aggressive interprofessional monitoring of cardiac hypertrophy and dietary reformation q
Factor
High Altitude (General, >2500m)
Kyrgyzstan
India (High Altitude-Ladakh/Spiti)
India (lowland/National)
Pakistan
Typical Altitude
>2500 m (defined threshold)
Sea level (Bishkek) to >3000 m
(40%+ of territory)
2600–4900 m
Near sea level
Mixed; lowlands
dominant
Hypertension
Prevalence
Varies; acute rise on arrival,
chronic effects complex
39–47% (rural); ~9% in
Bishkek urban screened
volunteers
~37% in Ladakh (2600–4900 m)
~21–24% nationally (NFHS-5)
~26% overall
Systolic BP Effect
+14 mmHg possible at 5,400 m
acutely
High, driven by lifestyle and
cold climate
Higher rise with age (~0.75
mmHg/year)
Lower age-related rise
Elevated diastolic
trends observed
Diastolic BP
Elevated acutely; +10 mmHg
at 5,400 m
Elevated
~76.9 mmHg lowland
Lower
Higher than
US/European
comparisons
Pulmonary
Hypertension
Common; hypoxia causes vasoconstriction
~20% of symptomatic highlanders in Tian-Shan region
Present in high-altitude natives
Not a major feature
Not a major feature
BP Increase with
Aging
Steeper at altitude
Very steep; surpasses
Western rates
lowlands
Moderate
Rises sharply after age
20; >60% in males >70
yrs
Key BP Drivers
Hypoxia → sympathetic
activation and vasoconstriction
Salt/fat diet, cold climate,
limited activity
Hypoxia and limited healthcare
access
Urbanization and dietary
changes
Urbanization, obesity,
hereditary
predisposition
Chronic Mountain
Sickness
Affects long-term highlanders
Documented in Kyrgyz
highlands
Present in Ladakhi population
Absent
Absent
BP Control Rate
Poor at altitude due to access
issues
Only ~14% of diagnosed cases
controlled
Very poor
~22.5% (2016–2020)
~12.5% controlled
Lowland vs. Highland
Within Region
Lowlanders may have higher
essential hypertension
Higher BP in highland zones
vs. Bishkek
Farmers/nomads show complex BP
profiles
Urban > Rural
Urban (26.6%) > Rural
(21%)
5. Clinical Management and Treatment Strategies
The management of hypertension at high altitude is distinct from sea-level practice. It requires a shift from simple pressure reduction to hemodynamic optimization, addressing hypoxia-driven sympathetic tone and hemorhaelogical changes.
In high-altitude medicine, the choice of antihypertensive is dictated by its effect on both systemic and pulmonary circulation.
• Calcium Channel Blockers (CCBs): Dihydropyridines (e.g., Nifedipine, Amlodipine) are the first-line preference. Unlike other classes, CCBs counteract Hypoxic Pulmonary Vasoconstriction (HPV), effectively lowering both systemic BP and pulmonary artery pressure, thereby reducing right ventricular afterload.
• ACE Inhibitors and ARBs: These are vital for patients showing signs of vascular remodeling. By inhibiting the Renin-Angiotensin-Aldosterone System (RAAS), they reduce arterial stiffness and medial hypertrophy. However, clinicians must monitor for acute kidney injury (AKI) in hikers or highlanders prone to dehydration.
• Beta-Blockers (Selective): Generally considered second-line. While they reduce SNS overactivation, non-selective beta-blockers may impair the chronotropic response necessary for exercise tolerance in hypoxic conditions.
Polycythemia is a hallmark of the Andean and Kyrgyz phenotypes, treating the blood is as important as treating the vessels.
• Isovolemic Hemodilution/Phlebotomy: In cases of Excessive Erythrocytosis (Hb > 19 g/dL), therapeutic phlebotomy is indicated. Removing 300–500 mL of blood reduces viscosity, improves microcirculation, and immediately lowers systemic vascular resistance.
• Anti-platelet Therapy: Due to the hyperviscosity and endothelial dysfunction mentioned in section 1.2, low-dose aspirin is often indicated to mitigate the increased risk of thrombotic events and stroke.
• Oxygen Therapy: For migrants or patients with acute hypertensive crises at altitude, supplemental oxygen acts as a potent vasodilator, rapidly reducing sympathetic drive and BP.
• Descent: The most definitive "treatment" for altitude-induced maladaptation is descent to a lower elevation, which reverses the primary trigger—hypoxia.
• Sodium and Fluid Regulation: Clinical counseling must emphasize strict sodium restriction to counter the fluid-retentive effects of hypoxia-induced RAAS activation.
• Primary Care & Nurses: Routine screening for Microalbuminuria and Left Ventricular Hypertrophy (LVH), as target organ damage often progresses faster under hypertension and hypoxia.
• Nutritionists: Designing diets that account for regional food availability while reducing the salt load.
• Nocturnal Support: For patients with severe hypertension, sleep apnea can me seen, nighttime supplemental oxygen or CPAP can the sympathetic surge, leading to a significant drop in daytime BP.
6. Comparative Blood Pressure Observations Among Diverse Populations in Kyrgyzstan
To better understand the impact of high-altitude exposure on blood pressure, we collected and analyzed data from multiple population groups residing in Kyrgyzstan, including Indian, Pakistani, and Egyptian immigrants, as well as native Kyrgyz individuals. This comparison allows for evaluation of how genetic background, duration of altitude exposure, lifestyle factors, and dietary habits influence cardiovascular adaptation.
The findings provide valuable insight into population-specific trends in blood pressure and help highlight potential risk factors or protective mechanisms across these diverse groups. The comparison table above summarizes the observed variations and key patterns among the studied populations.
Conclusion
High-altitude hypertension represents a critical divergence between evolutionary adaptation and chronic maladaptive responses to hypobaric hypoxia. While Tibetan and Ethiopian cohorts maintain homeostatic resilience, Andean and Kyrgyz populations exhibit significant vulnerability to High-Altitude Systemic Hypertension (HASH). This is driven by a multiple factor effecting for chronic sympathetic overactivation, hemorheological hyperviscosity from excessive erythropoiesis, and profound endothelial dysfunction.
Clinically, these mechanisms elevate systemic vascular resistance and trigger pulmonary vascular remodeling, increasing mean pulmonary artery pressure (mPAP) and right ventricular afterload. Management requires a shift to altitude-specific hemodynamic optimization, prioritizing dihydropyridine calcium channel blockers to counteract hypoxic pulmonary vasoconstriction and isovolemic hemodilution for severe erythrocytosis. Improving outcomes ultimately depends on an interprofessional framework integrating specialized pharmacotherapy, dietary reformation, and aggressive monitoring of target organ damage.
Authors Information-
Bhavika Chouhan (Medical student- 2nd year)
Zainab Mastim (Medical student- 2nd year)
Anshi Jaiswal (Medical student- 2nd year)
Syeda Inaya (Medical student- 2nd year)
Supervisor - Dr. Burhan Rajput (Faculty Member, Postdoctoral trainee)
General References
PubMed Central (PMC) (.gov) https://share.google/fNr1rcBpJsyUl2LBd
National Institutes of Health (.gov) https://share.google/NjxvUW1bkstMmONP7
American Heart Association Journals https://share.google/lcD8sH5pfPswKQgCd
World Health Organization (WHO) https://share.google/lVEPYWc0r7R3tynH6
https://iris.who.int/server/api/core/bitstreams/93b8e571-00a2-4de3-bb34-30f99b384816/content
https://www.who.int/news/item/19-09-2023-first-who-report-details-devastating-impact-of-hypertension-and-ways-to-stop-it
https://pmc.ncbi.nlm.nih.gov/articles/PMC4948792/
Altitude and hypertension Centre for Evidence-Based Medicine (CEBM), University of Oxford https://share.google/AixMKLpMdzDcJ5wgL
Systemic Hypertension at High Altitude | Hypertension https://share.google/Aa31N5oLpLxp2sw4d
https://share.google/Ovl5BxLNJTXxdk4Lt
AccessMedicine https://share.google/xsXNadfrQkeEuJsVH
Beall CM. "Human adaptation to high altitude." PNAS. 2023.
Bärtsch P, Gibbs JSR. "Effects of altitude on the heart and lungs." Lancet. 2024.
Grocott MPW, et al. "Mechanisms of hypoxia adaptation." NEJM. 2023.
Parati G, et al. "Blood pressure changes at altitude." Hypertension. 2024.
Moore LG. "Genetics of high-altitude adaptation." J Appl Physiol. 2025.